HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New Elite Feature: Screen & Chart at the same time

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

XORTX Therapeutics Inc.

Contributing Author

Recent Articles by XORTX Therapeutics Inc.

May-14
XORTX Announces US$5 Million Public Offering XRTX -14.10% GlobeNewswire
Apr-21
XORTX Meets Nasdaq Continued Listing Requirements XRTX +19.56% GlobeNewswire
Apr-13
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset XRTX -11.24% GlobeNewswire
Apr-01
XORTX Confirms Effective Date of Share Consolidation XRTX GlobeNewswire
Mar-26
XORTX Announces Results of Annual and Special Meeting of Shareholders XRTX +9.88% XRTX -9.69% GlobeNewswire
Mar-26
XORTX Announces Change of Effective Date of Share Consolidation XRTX +9.88% XRTX -9.69% GlobeNewswire
Mar-25
XORTX Announces Share Consolidation XRTX GlobeNewswire
Mar-24
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting XRTX GlobeNewswire
Mar-18
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders XRTX +6.45% GlobeNewswire
Mar-13
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation XRTX -10.89% GlobeNewswire
Mar-05
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders XRTX +7.78% GlobeNewswire
Feb-04
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems XRTX -17.71% XRTX GlobeNewswire
Dec-31
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update XRTX GlobeNewswire
Oct-29
XORTX Announces Closing of US$1.1 Million Registered Direct Offering XRTX GlobeNewswire
Oct-21
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering XRTX GlobeNewswire
Oct-20
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency XRTX GlobeNewswire
Oct-20
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency XRTX -31.82% GlobeNewswire
Oct-17
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems XRTX +29.41% GlobeNewswire
Sep-04
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10 XRTX GlobeNewswire
Sep-03
XORTX Initiates IND Preparation for XORLO in Gout Program XRTX GlobeNewswire
Aug-08
XORTX Completes USD $114,500 Private Placement XRTX GlobeNewswire
Aug-07
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026 XRTX +5.41% GlobeNewswire
Jul-31
XORTX Announces USD $114,500 Private Placement XRTX GlobeNewswire
Jul-22
XORTX Completes Non-Brokered Private Placement of Units XRTX -5.13% XRTX GlobeNewswire
Jun-26
XORTX Announces USD $925,000 Private Placement XRTX GlobeNewswire
May-19
XORTX Announces USD $3 Million Offering XRTX -14.02% GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)